Health Medical Breakthroughs Treatment

GSK’s Shingles Vaccine Shows High Efficacy Against Shingles in Phase III Study

Posted on Posted in Shingles News

(PR Newswire) According to a recent press release, GSK recently announced the publication of detailed results from a randomized phase III study (ZOE-70) of its investigational shingles vaccine, Shingrix™, showing 90% efficacy in adults aged 70 years and older that is maintained for at least four years. The results were published in the New England […]